Agencies Talk Cooperation On Medicines Access; Stakeholders Cautious 19/07/2010 by Catherine Saez, Intellectual Property Watch 1 Comment Key international agencies for health, trade and intellectual property on Friday jointly organised a symposium on access to medicines in an effort to gather information and expertise as a basis of a collaborative response to the challenges of public health.
AIDS Conference Campaigns For International Focus, Funding and Research 19/07/2010 by Catherine Saez, Intellectual Property Watch 1 Comment The 18th International AIDS conference opened its doors in Vienna on Sunday with a purpose of keeping the HIV issue high among international priorities in the context of a global economic crisis, and to promote universal access to treatment.
Hopes Fading For Concluding Biodiversity Access And Benefit Sharing Negotiations? 16/07/2010 by Catherine Saez, Intellectual Property Watch 2 Comments The clock was ticking with only a day to go in this week’s meeting of a UN working group on biodiversity trying to reach an agreement on a draft protocol text on access and benefit-sharing.
OECD Sees New Angle On Innovation For Growth, Social Challenges 16/07/2010 by Catherine Saez and William New, Intellectual Property Watch Leave a Comment Innovation is a key factor in economic growth but is not only about research as it is a system with many different interacting parts including R&D as one of those elements, a senior developed nations group representative said this week. Governments need to promote policies that integrate the cross-cutting nature of innovation and favour evidence based decision making, he said.
New Climate Technologies Rarely Reaching Developing Countries, Panel Says 13/07/2010 by Kaitlin Mara for Intellectual Property Watch 3 Comments Climate-friendly technologies are only rarely being transferred to developing countries, and then primarily to a small handful of emerging market economies, said the findings of a study presented today. That the changing global climate requires urgent response, and that this response will most likely include technology, is largely agreed. But what role intellectual property rights play in making sure that technology exists and is available is still not yet fully understood.
UN Biodiversity Talks Resume, Last Chance For Agreement Before October Deadline 09/07/2010 by Catherine Saez, Intellectual Property Watch Leave a Comment The last chance to complete discussions and reach an agreement on a draft protocol text on access and benefit-sharing is given to member parties of the UN Convention on Biodiversity (CBD) next week. The protocol is intended to provide a new international tool for governments against piracy of genetic resources.
Monsanto Soybean Patent Cannot Stretch To Processed Soy Meal, European Court Says 07/07/2010 by Catherine Saez, Intellectual Property Watch 3 Comments Yesterday, the European Court of Justice ruled in a case pitching Monsanto against European importers of Argentinean soy meal, denying the US seed giant intellectual property rights over the exports of soy meal from Argentina to the European Union.
WHO Flu Misconduct Debate Polarising As Independent Review Advances 07/07/2010 by Kaitlin Mara for Intellectual Property Watch 5 Comments “Exactly a year ago, a very bad decision was taken” by the World Health Organization that now seems “unscientific and irrational,” said Council of Europe parliamentarian Paul Flynn in a late June presentation of a new report on the WHO’s actions during the 2009 influenza pandemic. But opinions heard at an ongoing review of the WHO’s pandemic response were mixed, with some praising the organisation’s work to protect public health and others critiquing what they say is suspicious secrecy.
ACTA Negotiators Vow To Mesh With National-Level Rights; Withhold New Text 02/07/2010 by Monika Ermert for Intellectual Property Watch 4 Comments LUCERNE, SWITZERLAND – There was progress during the ninth round of negotiations for the Anti-Counterfeiting Trade Agreement (ACTA) this week in Lucerne, negotiators said over the last day, and in their final press communiqué they made promises that “ACTA will not interfere with a signatory’s ability to respect fundamental rights and liberties,” it would be consistent with World Trade Organization agreements and certainly “not hinder the cross-border transit of legitimate generic medicine.”
US Economist: US Financial Patents Litigation-Prone; Low Quality Makes Them Easy Targets 01/07/2010 by Catherine Saez, Intellectual Property Watch 1 Comment Filing of financial patents seems to be on a parallel upward trend with litigation in the United States, with large companies being prime targets, and individual or small entities owning the patents, according to a well-known US economist. This could be the consequence of low quality patents being granted, he said.